CHADS2, CHA2DS2-VASc and HAS-BLED as predictors of outcome in patients with atrial fibrillation undergoing percutaneous coronary intervention

Thrombosis Research

Volumn 133, Issue 4, 2014, Pages 560-566

  Puurunen, Marja K ^a   Kiviniemi, Tuomas ^b   Schlitt, Axel ^c   Rubboli, Andrea ^d   Dietrich, Britta ^c   Karjalainen, Pasi ^e   Nyman, Kai ^f   Niemelä, Matti ^g   Lip, Gregory Y H ^h   Airaksinen, K E Juhani ^b  

^a FINNISH RED CROSS BLOOD SERVICE   (Finland)

^b TURKU UNIVERSITY HOSPITAL   (Finland)

^c MARTIN LUTHER UNIVERSITY HALLE WITTENBERG   (Germany)

^d MAGGIORE HOSPITAL   (Italy)

^e SATAKUNTA CENTRAL HOSPITAL   (Finland)

^f CENTRAL FINLAND CENTRAL HOSPITAL   (Finland)

^g OULU UNIVERSITY HOSPITAL   (Finland)

^h UNIVERSITY OF BIRMINGHAM   (United Kingdom)

Author keywords

Atrial fibrillation; HAS BLED; PCI; Risk scoring schemes

Indexed keywords

ACUTE CORONARY SYNDROME; ADULT; ADVERSE OUTCOME; AGED; ARTERIAL THROMBOEMBOLISM; ARTICLE; BLEEDING; CARDIOVASCULAR MORTALITY; CEREBROVASCULAR ACCIDENT; CHA2DS2 VASC SCORE; CHADS2 SCORE; CORONARY STENT; FEMALE; FOLLOW UP; HAS BLED SCORE; HEART ATRIUM FIBRILLATION; HEART INFARCTION; HEART MUSCLE REVASCULARIZATION; HIGH RISK POPULATION; HUMAN; INTERNATIONAL NORMALIZED RATIO; LIVER FUNCTION; MAJOR CLINICAL STUDY; MALE; OBSERVATIONAL STUDY; PATIENT REFERRAL; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; PROGNOSIS; PROSPECTIVE STUDY; SCORING SYSTEM; STABLE ANGINA PECTORIS; STENT THROMBOSIS; TRANSIENT ISCHEMIC ATTACK; TREATMENT OUTCOME; CLINICAL TRIAL; MULTICENTER STUDY; PATHOPHYSIOLOGY; PROCEDURES; RISK ASSESSMENT; RISK FACTOR; STROKE; THROMBOEMBOLISM;

AGED; ATRIAL FIBRILLATION; FEMALE; HUMANS; MALE; PERCUTANEOUS CORONARY INTERVENTION; PROGNOSIS; RISK ASSESSMENT; RISK FACTORS; STROKE; THROMBOEMBOLISM; TREATMENT OUTCOME;

EID: 84896124458     PISSN: 00493848     EISSN: 18792472     Source Type: Journal    
DOI: 10.1016/j.thromres.2014.01.007     Document Type: Article

References (15)

1. G.Y. Lip, R. Nieuwlaat, R. Pisters, D.A. Lane, and H.J. Crijns Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: the euro heart survey on atrial fibrillation Chest 137 2 2010 263 272
2. J.B. Olesen, G.Y. Lip, M.L. Hansen, P.R. Hansen, J.S. Tolstrup, and J. Lindhardsen et al. Validation of risk stratification schemes for predicting stroke and thromboembolism in patients with atrial fibrillation: nationwide cohort study BMJ 342 2011 d124
3. A.J. Camm, G.Y. Lip, R. De Caterina, I. Savelieva, D. Atar, and S.H. Hohnloser et al. ESC Committee for Practice Guidelines-CPG; Document Reviewers. 2012 focused update of the ESC Guidelines for the management of atrial fibrillation: an update of the 2010 ESC Guidelines for the management of atrial fibrillation - developed with the special contribution of the European Heart Rhythm Associatio Europace 14 10 2012 1385 1413
4. D. Poli, E. Antonucci, R. Marcucci, C. Fatini, B. Alterini, and L. Mannini et al. Gensini GF, and Prisco D Risk of bleeding in very old atrial fibrillation patients on warfarin: relationship with ageing and CHADS2 score Thromb Res 121 3 2007 347 352
5. E.M. Hylek, C. Evans-Molina, C. Shea, L.E. Henault, and S. Regan Major hemorrhage and tolerability of warfarin in the first year of therapy among elderly patients with atrial fibrillation Circulation 115 21 2007 2689 2696
6. M. Hughes, and G.Y. Lip Guideline Development Group for the NICE national clinical guideline for management of atrial fibrillation in primary and secondary care. Risk factors for anticoagulation-related bleeding complications in patients with atrial fibrillation: a systematic review QJM 100 10 2007 599 607
7. G.Y. Lip, F. Andreotti, L. Fauchier, K. Huber, E. Hylek, and E. Knight et al. Document reviewers: Collet JP, Rubboli A, Poli D, Camm J. Bleeding risk assessment and management in atrial fibrillation patients: a position document from the European Heart Rhythm Association, endorsed by the European Society of Cardiology Working Group on Thrombosis Europace 13 5 2011 723 746
8. L. Friberg, M. Rosenqvist, and G.Y. Lip Net clinical benefit of warfarin in patients with atrial fibrillation: a report from the Swedish atrial fibrillation cohort study Circulation 125 19 2012 2298 2307
9. D. Poçi, M. Hartford, T. Karlsson, J. Herlitz, N. Edvardsson, and K. Caidahl Role of the CHADS2 score in acute coronary syndromes: risk of subsequent death or stroke in patients with and without atrial fibrillation Chest 141 6 2012 1431 1440
10. J.M. Ruiz-Nodar, F. Marín, V. Roldán, J. Valencia, S. Manzano-Fernández, and L. Caballero et al. Should we recommend oral anticoagulation therapy in patients with atrial fibrillation undergoing coronary artery stenting with a high HAS-BLED bleeding risk score? Circ Cardiovasc Interv 5 4 2012 459 466
11. P. Gallego, V. Roldán, J.M. Torregrosa, J. Gálvez, M. Valdés, and V. Vicente et al. Relation of the HAS-BLED bleeding risk score to major bleeding, cardiovascular events, and mortality in anticoagulated patients with atrial fibrillation Circ Arrhythm Electrophysiol 5 2 2012 312 318
12. D.E. Cutlip, S. Windecker, R. Mehran, A. Boam, D.J. Cohen, and G.A. van Es et al. Serruys PW; Academic Research Consortium. Clinical end points in coronary stent trials: a case for standardized definitions Circulation 115 2007 2344 2351
13. R. Mehran, S.V. Rao, D.L. Bhatt, C.M. Gibson, A. Caixeta, and J. Eikelboom et al. Standardized bleeding definitions for cardiovascular clinical trials: a consensus report from the bleeding academic research consortium Circulation 123 2011 2736 2747
14. T. Pilgrim, B. Kalesan, T. Zanchin, C. Pulver, S. Jung, and H. Mattle et al. Impact of atrial fibrillation on clinical outcomes among patients with coronary artery disease undergoing revascularisation with drug-eluting stents EuroIntervention 8 9 2013 1061 1071
15. J.G. Smith, M. Wieloch, S. Koul, O. Braun, J. Lumsden, and E. Rydell et al. Triple antithrombotic therapy following an acute coronary syndrome: prevalence, outcomes and prognostic utility of the HAS-BLED score EuroIntervention 8 6 2012 672 678